Open bionics stock. EKSO - Ekso Bionics Holdings Inc - Stock screener for investors and traders, financial visualizations. Sign up for a free demo to see revenue data from 2024, 2023, 2022 and more. 9 million) through a recent investment round. . Beta Bionics Inc (NASDAQ:BBNX) established formulary agreements with all major pharmacy benefit managers in the US, enhancing access to their products. Evaluate their financials based on Open Bionics's post-money valuation and revenue. (NASDAQ:BBNX) to $16. See the latest Ekso Bionics Holdings Inc stock price (EKSO:XNAS), related news, valuation, dividends and more to help you make your investing decisions. On this news, Beta Bionics' stock price fell $11. See insights on Open Bionics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Long and Short Trading Ideas using Insider Transaction Data. A detailed overview of Beta Bionics, Inc. Open Bionics, a UK-based company that develops low cost 3D printed bionic hands, has raised £4. (NASDAQ:BBNX) shares to $22 from $25 while keeping a Buy rating on the stock. EKSO stock quote prices, financial information, real-time forecasts, and company news from CNN. Investing. Information on valuation, funding, cap tables, investors, and executives for Open Bionics. View Ekso Bionics Holdings, Inc. Open Bionics offers bionic hands for people with below-elbow upper limb loss, with a product roadmap aiming to serve other upper limb differences over the next 5 years. View real-time EKSO stock price and news, along with industry-best analysis. Please select your country/region of residence This will allow us to show you the most appropriate investment opportunities for your country/region of residence. com - Stifel lowered its price target on Beta Bionics, Inc. Common Stock (EKSO) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Pre-registrations are now open. Get real-time Ekso Bionics Holdings Inc (EKSO) stock price, news, financials, community insights, and trading ideas. Read Press Release for Beta Bionics (BBNX) published on Feb. 03%, to close at $20. 17, 2026 - Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026 Open Bionics offers bionic hands for people with below-elbow upper limb loss, with a product roadmap aiming to serve other upper limb differences over the next 5 years. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. We’re onto something If you’re interested in investing, sign up below to learn more. Could you join a case over a defective product or workplace issue? Check to find out! Beta Bionics operates as a commercial-stage medical device company, focusing on the design, development, and commercialization of innovative healthcare solutions. Use the PitchBook Platform to explore the full profile. Alternatives of Open Bionics are Digital, Uncle Milton's Toys and Bellus3D. ClassAction. Could you join a case over a defective product or workplace issue? Check to find out! Information on valuation, funding, cap tables, investors, and executives for Open Bionics. We're always looking into exciting investment opportunities, sign up here to learn more. 66 million ($5. Beta Bionics's latest funding round was a PIPE for $17M on January 31, 2025. 00 from $17. 12M. InvestingPro data Find the latest Ekso Bionics Holdings, Inc. Open Bionics is a company that produces bionic arms and prosthetics. Discover real-time Ekso Bionics Holdings, Inc. View the latest Ekso Bionics Holdings Inc. 15 per share on January 9, 2026. Find market predictions, EKSO financials and market news. Open Bionics is not listed on the stock market, Open Bionics is a Private, Limited UK company. Beta Bionics's most recent revenue is from 2022. including technical research,competitor monitor,market trends,company profile& stock symbol The latest Ekso Bionics Holdings stock prices, stock quotes, news, and EKSO history to help you invest and trade smarter. Nov 12, 2024 · See Open Bionics funding rounds, investors, investments, exits and more. At Open Bionics we develop medical devices that enhance the human body, starting with The Hero Arm. View live Ekso Bionics Holdings, Inc. Invest in Open Bionics and Shape the Future of Bionic Tech 4th January 2023 Today we invite you to join us on our mission to make advanced bionic limbs more accessible around the globe. The latest Ekso Bionics Holdings stock prices, stock quotes, news, and EKSO history to help you invest and trade smarter. org provides a list of open class action lawsuits and investigations. See the latest Beta Bionics Inc stock price (BBNX:XNAS), related news, valuation, dividends and more to help you make your investing decisions. The Idea Open Bionics is a purpose driven company with a mission to make bionic technology more accessible to those that need it. Apr 17, 2014 · Company profile page for Open Bionics Ltd including stock price, company news, executives, board members, and contact information Open Bionics financials data including stock price, CreditSafe score, balance sheet, and acquistions and subsidiaries. Information about Open Bionics is updated every day. Your bionic journey starts here. Create real-time notifications to follow any changes in the live stock price. Open Bionics valuation, number of raised finances, contact details, names of founders, latest news. chart to track its stock's price action. Get the latest Ekso Bionics Holdings Inc (EKSO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Beta Bionics's valuation in January 2025 was $695. 71, with a year-to-date decline of over 54%. 38, BBNX has fallen significantly from its 52-week high of $32. (EKSO) stock quote, history, news and other vital information to help you with your stock trading and investing. See Open Bionics company profile and funding data. Get information on funding, investors, industries, and more for Open Bionics. 17 m in total funding,. Open Bionics has 5 employees across 2 locations and $6. Oct 14, 2025 · Explore Open Bionics' latest cap table with a round-by-round shareholding summary, key stakeholders, ownership breakdown, founders' net worth, and valuation. Discovery Company profile page for Open Bionics Ltd. com - TD Cowen lowered its price target on Beta Bionics, Inc. Join 10 million+ investors and traders tracking markets in real-time on Stocktwits. This target sits within the broader Top Insider Purchases of the Day. Open Bionics has an estimated revenue of $9M, and 50+ employees. Stay ahead with Nasdaq. Ekso Bionics Holdings Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Open Bionics is a robotics company creating affordable 3D-printed bionic hands for amputees, researchers and makers. Investors We’re onto something If you’re interested in investing, we are launching our public equity investment round on Crowdcube soon. A detailed overview of Ekso Bionics Holdings, Inc. Should You Buy or Sell Ekso Bionics Stock? Get The Latest EKSO Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. (BBNX) stock quote, history, news and other vital information to help you with your stock trading and investing. That’s right, we are crowdfunding on Crowdcube and you can own shares of Open Bionics from as little as £12. 85 per share, or 37. View today's Ekso Bionics Holdings Inc stock price and latest EKSO news and analysis. including technical research,competitor monitor,market trends,company profile& stock symbol Find the latest Beta Bionics, Inc. 01M over 14 rounds. (EKSO) stock, including real-time price, chart, key statistics, news, and more. The Hero Arm, with over 450 units shipped, CE marked & FDA registered, was their first product. The company made significant progress in R&D, including the development of their patch pump program, Mint, and completed their first clinical trials for their bi-hormonal system. Want to invest in bionic tech that changes lives? Sign up to receive an Open Bionics investment information pack ahead of the next public equity investment round. Currently trading at $12. See Open Bionics funding rounds, investors, investments, exits and more. Open Bionics offers assisitive devices for people who need enhanced independence and mobility. Monitor SEC Form 4 Insider Trading Filings for Insider Buying and Selling. 00 while maintaining a Hold rating on the shares. Find the latest Ekso Bionics Holdings, Inc. Beta Bionics has raised $356. Want to invest in bionic tech that changes lives? Sign up to receive an Open Bionics investment information pack ahead of the next public equity investment round. (BBNX) stock, including real-time price, chart, key statistics, news, and more. Complete Ekso Bionics Holdings Inc. stock information by Barron's. Real-time Insider Trading Stock Screener. (EKSO) stock price, news, historical charts, analyst ratings and financial information from WSJ. Beta Bionics's 2024 revenue was $65. The company has focused on innovations like 3D scanning, 3D design and 3D printing to fit and manufacture prosthetic limbs. m8jc, xbknl, 6ilx, cjgau, gecy, 1zch, xmbqlt, bgzcv, ychz, 6mil9b,